|
11/09/2024
|
07:00
|
Cancellation - BiVictriX Therapeutics plc
|
RNS
|
|
10/09/2024
|
11:04
|
Holding(s) in Company
|
RNS
|
|
10/09/2024
|
07:00
|
Last Day of Dealings
|
RNS
|
|
09/09/2024
|
07:00
|
Positive In Vivo Data from BVX002 Programme
|
RNS
|
|
02/09/2024
|
17:04
|
Holding(s) in Company
|
RNS
|
|
02/09/2024
|
08:50
|
Director Dealing
|
RNS
|
|
29/08/2024
|
17:05
|
Result of General Meeting
|
RNS
|
|
28/08/2024
|
10:14
|
Holding(s) in Company
|
RNS
|
|
28/08/2024
|
10:12
|
Holding(s) in Company
|
RNS
|
|
19/08/2024
|
07:00
|
TR-1: Notification of major holdings
|
RNS
|
|
13/08/2024
|
07:00
|
Grant of Options
|
RNS
|
|
12/08/2024
|
07:00
|
Proposed Voluntary Delisting
|
RNS
|
|
01/08/2024
|
07:00
|
Interim Results
|
RNS
|
|
24/07/2024
|
17:00
|
Result of Annual General Meeting
|
RNS
|
|
26/06/2024
|
07:00
|
Publication of 2023 Annual Report & Notice of AGM
|
RNS
|
|
13/06/2024
|
07:00
|
Compelling Safety Profile of BVX001
|
RNS
|
|
06/06/2024
|
07:00
|
Innovate UK Grant Award to Accelerate ADC Pipeline
|
RNS
|
|
31/05/2024
|
08:44
|
BiVictriX – Full Year Results 2023
|
RNS
|
|
17/04/2024
|
07:00
|
Orphan Drug Designation & FDA INTERACT Meeting
|
RNS
|
|
28/03/2024
|
07:00
|
Grant of Options – PDMR/Director Dealings
|
RNS
|
|
04/01/2024
|
12:30
|
Holding(s) in Company
|
RNS
|
|
04/01/2024
|
12:30
|
Holding(s) in Company
|
RNS
|
|
04/01/2024
|
07:00
|
BiVictriX Hosts Inaugural Roundtable Discussion
|
RNS
|
|
05/12/2023
|
11:08
|
Board Change
|
RNS
|
|
30/11/2023
|
07:00
|
Pipeline update on BVX002
|
RNS
|
|
22/11/2023
|
17:14
|
Holding(s) in Company
|
RNS
|
|
15/11/2023
|
07:00
|
Patent Granted in Japan
|
RNS
|
|
12/10/2023
|
07:00
|
Extended Survival Rates Reported with BVX001
|
RNS
|
|
03/10/2023
|
07:00
|
Appointment of Adrian Howd as CFO and CBO
|
RNS
|
|
19/09/2023
|
07:00
|
Interim Results
|
RNS
|
|
31/08/2023
|
07:00
|
Total Voting Rights
|
RNS
|
|
23/08/2023
|
07:00
|
US Patent Granted
|
RNS
|
|
17/08/2023
|
07:00
|
Holding(s) in Company
|
RNS
|
|
16/08/2023
|
18:00
|
Holding(s) in Company
|
RNS
|
|
11/08/2023
|
16:17
|
Holding(s) in Company
|
RNS
|
|
08/08/2023
|
17:18
|
Result of General Meeting
|
RNS
|
|
19/07/2023
|
18:16
|
Result of Conditional Fundraise
|
RNS
|
|
19/07/2023
|
12:31
|
Proposed Fundraise in excess of £2 million
|
RNS
|
|
17/07/2023
|
07:00
|
Positive final data in preclinical efficacy study
|
RNS
|
|
19/06/2023
|
07:00
|
Positive interim data
|
RNS
|
|
06/06/2023
|
07:00
|
BiVictriX nominates clinical candidate for BVX001
|
RNS
|
|
04/05/2023
|
16:36
|
Result of Annual General Meeting
|
RNS
|
|
31/03/2023
|
07:00
|
Publication of Annual Report and Notice of AGM
|
RNS
|
|
30/03/2023
|
07:00
|
BiVictriX Full Year Results
|
RNS
|
|
01/03/2023
|
07:01
|
Appointment of Alex Hughes as CFO
|
RNS
|
|
31/01/2023
|
07:08
|
BiVictriX reports positive BVX001 preclinical data
|
RNS
|
|
24/01/2023
|
16:21
|
Holding(s) in Company
|
RNS
|
|
19/01/2023
|
11:00
|
Holding(s) in Company
|
RNS
|
|
19/01/2023
|
07:00
|
Holding(s) in Company
|
RNS
|
|
16/01/2023
|
16:32
|
Holding(s) in Company
|
RNS
|